Fibrillary astrocytoma

Lore & Background

Fibrillary astrocytomas are low-grade tumors with a slow rate of growth, allowing patients to survive longer than those with more aggressive brain tumors like glioblastoma multiforme. Early symptoms include seizures, frequent mood changes, headaches, and hemiparesis (weakness on one side of the body). Diagnosis often involves CT or MRI scans showing a diffuse mass that does not enhance with contrast dye; continuous EEG may help localize seizure activity, and a biopsy may confirm the tumor's nature.

Reader's Guide

The significance of fibrillary astrocytomas lies in their infiltrative growth pattern, which complicates treatment. The microscopic tentacles intermingle with healthy brain cells, making complete surgical resection difficult without harming neurological function. Surgery can reduce tumor size, but incomplete resection may lead to recurrence. Standard radiotherapy (10 to 30 sessions) and radiosurgery are used to improve outcomes, while chemotherapy improves overall survival but is effective in only about 20% of cases. Researchers are investigating gene therapy, immunotherapy, and novel chemotherapies. Despite challenges, the slow growth rate offers patients a relatively better prognosis compared to high-grade gliomas.

Did You Know?

• Fibrillary astrocytomas are also called diffuse astrocytomas because their borders are not clearly visible on scans.
• Response to chemotherapy for fibrillary astrocytoma varies widely depending on tumor grade, treatment protocol, and molecular markers such as IDH mutation status, so no single effectiveness rate is universally accepted.
• Patients with this tumor commonly survive longer than those with glioblastoma multiforme.